CRISPR Reagents

DBT Gene Knockout Kit (Human)

Knockout any human or mouse protein-coding gene with XDel technology.

Bulk Upload
Need a quote? Add to cart and download one instantly at checkout — to reference on a purchase order, submit for budget approval, or keep for your records. No need to contact sales.

The branched-chain alpha-keto acid dehydrogenase complex (BCKD) is an inner-mitochondrial enzyme complex involved in the breakdown of the branched-chain amino acids isoleucine, leucine, and valine. The BCKD complex is thought to be composed of a core of 24 transacylase (E2) subunits, and associated decarboxylase (E1), dehydrogenase (E3), and regulatory subunits. This gene encodes the transacylase (E2) subunit. Mutations in this gene result in maple syrup urine disease, type 2. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Molecular Function5
Biological Process2
Cellular Component4

Common questions about the DBT knockout kit

How many guides does the DBT knockout kit use?
The kit's XDel design targets DBT with 3 guides, and the earliest cut is in exon 6 of its canonical transcript.
Which DBT transcripts does the knockout cut?
The XDel guides cut 13 DBT transcripts, including the canonical transcript ENST00000370132. They cut all 4 of its CCDS protein-coding transcripts.
Do the DBT guides cut other genes?
No. Our design analysis predicts no off-target potential in any other gene for these guides.
Gene Knockout Kits Provide Superior Editing Efficiency in iPSC, Immortalized, and Primary Cells and Consistent Protein Depletion Using the XDel Design
XDel is a cutting-edge CRISPR knockout technology designed to remove the guesswork from gene editing. By leveraging an innovative guide RNA design strategy, XDel delivers highly efficient, consistent, and reproducible gene knockouts—empowering researchers to accelerate their discoveries with confidence.